Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02373683 · ClinicalTrials.gov registry record · NA
Helium-oxygen Gas Mixtures Delivered by a High Flow Nasal Cannula in Bronchiolitis
A NA study, sponsored by Case Western Reserve University.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02373683 is a NA study that was terminated before completion, run by Case Western Reserve University. The registered enrollment target is 10 participants.
The verdict
NCT02373683, a NA study, was terminated before completion, sponsored by Case Western Reserve University.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The aim of this prospective pilot study is to determine the effect of heliox delivered via a proprietary calibrated heated and humidified high flow nasal cannula (HFNC) system (Vapotherm Precision Flow Heliox) in children ages 0-24 months with severe bronchiolitis.
Interventions
- DEVICE Vapotherm-Heliox
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02373683
The ClinicalTrials.gov registry entry for NCT02373683 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vapotherm-Heliox is the first listed.
NCT02373683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02373683 about?
NCT02373683 is a clinical study titled "Helium-oxygen Gas Mixtures Delivered by a High Flow Nasal Cannula in Bronchiolitis". The aim of this prospective pilot study is to determine the effect of heliox delivered via a proprietary calibrated heated and humidified high flow nasal cannula (HFNC) system (Vapotherm Precision Flow Heliox) in children ages 0-24 months with severe bronchiolitis.
What is the current status of trial NCT02373683?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2014-12. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02373683?
The interventions under investigation include: Vapotherm-Heliox (DEVICE).
Who is sponsoring clinical trial NCT02373683?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.